Analytics Platforms

Here we will look into developing proper solutions for the demands of biologists and scientists across large pharma companies. 

 

ANALYTICS PLATFORMS, Wednesday 4 December 2019

08:00

Registration and Refreshments

09:00

Keynote [Reserved for Roche CEO]

09:20

Title Sponsor

Frank Lee
09:40

Getting your data and applications ready for precision medicine

  • Learn about key capabilities of the underlying reference architecture for high performance data and AI (HPDA) to manage the ocean of data and optimize your AI and big data pipelines for analysis.
  • Understand how to improve data quality through advanced metadata management using content-based and policy-driven data classification & tagging.
  • Discover how to support hybrid multicloud workload orchestration with end-to-end automation of workflows, leveraging containers and cloud using a self-service 'App Hub'.
  • Hear about use cases from the world's fastest genomics pipeline to the largest variant database and explore how your organization can improve speed, scalability, collaboration and ease of use and gain significant cost efficiencies
Georges Heiter
10:00

New Frontiers in Data Science – the role of automation in accelerating scientific discovery

10:40

Speed Networking

11:00

Morning refreshments

round tables
11:40

Roundtables

(click to see full list)
Accelerating operations and analytics with High Speed Data sharing across platforms and the world
Laurent Martin

Laurent Martin, Aspera Pre-Sales Engineer - EMEA, IBM Global Markets

Data collection & algorithmic training for biomedical tasks: utilisation and strategies
Anastasia Georgievskaya

Anastasia Georgievskaya, General Manager, Haut.AI

Data Lakes, Getting data ready for analytics, and Personalized Health Data
Christian Blumenroehr

Christian Blumenroehr, Principal Scientist, F. Hoffmann-La Roche

Data Privacy and Democratisation
Matthew Rooney

Matthew Rooney, Chief Clinical Information Officer, Heart of England NHS Foundation Trust

Dell EMC
Design thinking: Driving forwards innovation in pharmaceuticals
Hermann Tribukait

Hermann Tribukait, Founder & CEO, ChemOS Inc.

Diagnosis based on genetic information and public ontologies and databases, improving the diagnosis process of rare disease patients with Foundation29
Pablo Botas

Pablo Botas, Head of Science, Foundation 29

Digital transformation across pharma
Jessica Federer

Jessica Federer, Ex Chief Digital Officer, Bayer

How big data is effecting precision oncology
Andrej Benjak

Andrej Benjak, Bioinformatician, University of Bern

IMI - EDHEN + BD4BO- The pro’s and con’s of the different IMI projects approaches. IT and high tech aspects. Gaining insights into the technical approaches to working with Real World Data at scale. Central vs. Federated; Working to promote FAIR principles
Matthew Wiener

Matthew Wiener, Director, Informatics And Predictive Sciences, Celgene

Investment in AI and Healthcare in China
Vibhor Gupta

Vibhor Gupta, Director and Founder, Pangaea Data

Is bad User Experience (UX) hindering drug discovery? What are the challenges and opportunities for UX in life science software and digital transformation?
Ronald Johnston

Ronald Johnston, Director Of Product And E-Commerce, Merck Digital

Lessons learned in running an AI-enabled operation for precision medicine – privacy, policy, and technical challenges and how we overcame them
Florina Ciorba

Florina Ciorba, Professor Hpc, University Basel

NTT Data
Partnerships across Pharma and Tech – Deals, IP and Timelines
Miron Tokarski

Miron Tokarski, CEO, Genomtec

Phage Display AI and Genomics – Using next generation AI and phage display to generate new immunological targets
Christian Bender

Christian Bender, Data Scientist, Bayer

Reproducibility in Bioinformatics and Big Data Analytics: Myth or Reality?
Raffaele Calogero

Raffaele Calogero, Professor, University of Torino

Roche
Roche - All4IBD: a Digital Medicine Toolkit to transform care in Inflammatory Bowel Disease (IBD)
Sumanjit Sethi

Sumanjit Sethi, Digital Health Leader, Immunology, Infectious Diseases and Ophthalmology, F. Hoffmann-La Roche Ltd

Roche - Analytical challenges with multimodal patient data: deriving drug development insights from clinico-molecular data
Gunther Jansen

Gunther Jansen, Group Director, PHC Data Science Analytics, Roche

Takeda
There is no AI without IA: Building a solid Information Architecture for your AI and high performance Precision Medicine
Frank Lee

Frank Lee, PhD, Global Healthcare and Life Sciences Industry Leader, IBM Systems

Title TBC
Visualisation of good quality data and the pursuit of metrics to drive efficiencies in clinical trials
Paolo Piraino

Paolo Piraino, Head Of Genomics And Biomarker Statistics, Bayer

Western Digital
12:30

Networking Lunch

ANALYTICS PLATFORMS
13:55

DNAnexus

Jobst Loeffler
ANALYTICS PLATFORMS
14:15

Integrating a validated R environment into a company-wide analytics platform for Life Science R&D

14:35

Afternoon Refreshments

ANALYTICS PLATFORMS
15:05

Chairs remarks

Peter Speyer
ANALYTICS PLATFORMS
15:10

Data Lakes, Getting data ready for analytics, and Personalized Health Data

Misha Kapushesky
ANALYTICS PLATFORMS
15:30

Genestack

Etzard Stolte
ANALYTICS PLATFORMS
15:50

Building Roches Global Data Catalogue

16:10

Afternoon Refreshments

ANALYTICS PLATFORMS
16:50

Chairs remarks

ANALYTICS PLATFORMS
16:55

Sponsor presentation

Lena Granovsky
ANALYTICS PLATFORMS
17:15

Digital transformation across pharma

Ishaan Nerurkar
ANALYTICS PLATFORMS
17:35

Discover how pharmaceutical companies are leveraging mathematically proven privacy to unlock value across internal silos and form data partnerships

William Paiva
ANALYTICS PLATFORMS
17:55

Smart Investments in AI and Health – Driving value into hearlthcare using AI

18:15

Drinks Reception

last published: 22/Oct/19 09:35

ANALYTICS PLATFORMS, Thursday 5 December 2019

08:30

Presentation [Reserved Novartis CEO]

10:00

Western Digital

11:05

Networking break

round tables
11:45

Roundtables

(Click to see full list)
Analytical challenges with multimodal patient data: deriving drug development insights from clinico-molecular data
Gunter Jansen

Gunter Jansen, Group Director, PHC Data Science Analytics, Roche

Data privacy sharing and analytics how technology can help
Andrew Roddam

Andrew Roddam, Vice President And Global Head Epidemiology, GSK

DELL
Developing a Spin in Bioinformatics Company
Nadeem Sarwar

Nadeem Sarwar, Founder And President, Eisai

Digital Biomarkers as endpoints in clinical trials: an opportunity for Personalised Healthcare
Christian Gossens

Christian Gossens, Digital Biomarker Informatics; Global Area Head; pRED Informatics, Roche

Digital transformation in pharma
Jessica Federer

Jessica Federer, Ex Chief Digital Officer, Bayer

Digital Transformation of Health Care
Markus Mäkelä

Markus Mäkelä, Co-Founder, PredictCare LLC

Educating data scientists for the pharmaceutical industry
Jake Chen

Jake Chen, Chief Bioinformatics Officer, University of Alabama at Birmingham

IBM
IMI - The need for data communities in Europe, and why should you care? Looking ahead to an integrated European research meeting the need for RWD in a global environment.
Kiliana Suzart-Woischnik

Kiliana Suzart-Woischnik, Epidemiology Director, Bayer

Learnings and results from large-scale investments in data across the pharmaceutical R&D chain
Greg Temesi

Greg Temesi, Director, R&D It - Product Strategy, Merck

Point of Care Diagnostics
Miron Tokarski

Miron Tokarski, CEO, Genomtec

Roche - All4IBD: a Digital Medicine Toolkit to transform care in Inflammatory Bowel Disease (IBD)
Sumanjit Sethi

Sumanjit Sethi, Digital Health Leader, Immunology, Infectious Diseases and Ophthalmology, F. Hoffmann-La Roche Ltd

Stop talking about the principles, start showing what FAIR really means - Gaps in IT capabilities to support FAIR data and services
Martin Romacker

Martin Romacker, Data And Information Architect, Roche

Wearable data and challenges around it that involve data ingestion, technology required for computation, data preprocessing and transformation and advanced analytics methods
Stephan Cichos

Stephan Cichos, Principal Data Manager, Bayer

Western Digital
Colm Carroll
12:30

IMI Lunchtime Panel- It is now or never! Connecting data communities with clinical research communities

How do we link research interests at scale and across data permeable borders in Europe? Building at scale communities; Expanding the FAIR principles in the EU; Understanding the quid pro quo between data partners and researchers.
  • Building at scale communities
  • Expanding the FAIR principles in the EU
  • Understanding the quid pro quo between data partners and researcher
Colm Carroll, Scientific Project Manager, Innovative Medicines Initiative
12:30

Lunch

ANALYTICS PLATFORMS
13:30

Chair's remarks

Roman Affentranger
ANALYTICS PLATFORMS
13:35

A new compound platform for enhanced access to chemical space for screening

ANALYTICS PLATFORMS
13:55

Sponsor Presentation

14:35

Afternoon Refreshments

ANALYTICS PLATFORMS
15:05

Chair's remarks

Gerald Hall
ANALYTICS PLATFORMS
15:10

Integrating a Variety of Gene Expression and Cytokine Analysis Platforms for Informative MOA Studies in Preclinical Models

ANALYTICS PLATFORMS
15:30

Sponsor Presentation

Milan Bates
ANALYTICS PLATFORMS
15:50

Process mining in the real time and situations in hospital settings, prediction and decision makings

16:30

Afternoon Refreshments

ANALYTICS PLATFORMS
17:00

Chair's remarks

Nareen Katta
ANALYTICS PLATFORMS
17:05

Using Analytics within the World of Clinical

Karim Lekadir
ANALYTICS PLATFORMS
17:25

euCanSHare H2020 project: building a big data multi-centre platform for enhancing data sharing and personalised medicine research in cardiology

Leonids Aleksandrovs
ANALYTICS PLATFORMS
17:45

HPC and Big Data in the cloud

18:05

Close of Conference

last published: 22/Oct/19 09:35

 

Contact us

To sponsor or exhibit contact:
Alistair Wilmot
+44 (0)207 092 1174

alistair.wilmot@terrapinn.com


To speak:
Chris Shanks
+44 (0)207 092 1151

chris.shanks@terrapinn.com